Assessment of feasibility for use of Parsortix derived circulating tumour cell (CTC) DNA with Myriad Genetics' existing tissue-based diagnostic test GUILDFORD, SURREY / ACCESS Newswire / August 20, ...

NORTHVALE, NJ / ACCESS Newswire / August 19, 2025 / ADM Tronics Unlimited, Inc. (OTCQB:ADMT), a technology-based developer and manufacturer of innovative technologies and products, announces results ...

Jaguar CEO Lisa Conte presenting August 20 at Emerging Growth Conference to provide updates on near-term catalysts; Click here to registerAs announced, initial proof-of-concept results from the ...

CREMONA, AB / ACCESS Newswire / August 19, 2025 / CannaPharmaRX, Inc. (OTC PINK:CPMD), an emerging leader in global cannabis cultivation and exports, announces a series of strategic developments. The ...

ALEXANDRIA, VA / ACCESS Newswire / August 19, 2025 / The American Society of Consultant Pharmacists (ASCP) proudly announces the appointment of Chief Executive Chad Worz, PharmD, BCGP, FASCP, to the ...

KENNESAW, GA / ACCESS Newswire / August 19, 2025 / The world of healthcare has changed drastically since the COVID-19 pandemic, and as both hospitals and SNFs are increasingly tasked with doing more ...

Accelerated Round Completion Positions Company for New Drug Application (NDA) Submission and Commercial Launch Partnerships RALEIGH, NORTH CAROLINA / ACCESS Newswire / August 19, 2025 / Belhaven ...

DENVER, COLORADO / ACCESS Newswire / August 19, 2025 / ForCast Orthopedics today announced the expansion of its Scientific Advisory Board (SAB) with the addition of Matthew P. Abdel, MD, and R.

GRAND RAPIDS, MI / ACCESS Newswire / August 19, 2025 / SpendMend, a leading provider of solutions to optimize the cost-cycle ...

POTOMAC, MARYLAND / ACCESS Newswire / August 19, 2025 / IGC Pharma, Inc. ("IGC" or the "Company") (NYSE American:IGC), a clinical-stage biotechnology company leveraging AI to develop innovative ...

MESA, ARIZONA / ACCESS Newswire / August 19, 2025 / Medical Care Technologies Inc. (OTC Pink:MDCE) today provided a corporate update highlighting important operational progress and structural ...

As announced, initial proof-of-concept results from the ongoing investigator-initiated trial in Abu Dhabi show crofelemer reduced the required total parenteral nutrition in the first participating ...